Renee Perdok

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 905 citations

Medicine, Pharmacology, Pharmacotherapy +15

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Raymond S. Douglas, George J. Kahaly, Amy Patel et al. · New England Journal of Medicine · 2020 · 700 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +11

Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial

Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2007 · 297 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Philip J. Mease, P A Ory, John T. Sharp et al. · Annals of the Rheumatic Diseases · 2008 · 267 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

Mark C. Genovese, Philip J. Mease, G. T. D. Thomson et al. · PubMed · 2007 · 190 citations

Medicine, Pharmacology, Pharmacotherapy +17